A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

NCT06151418 · clinicaltrials.gov ↗

COMPLETED

Status

2313

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Novel hormonal therapy

Sponsor

Pfizer

Collaborators

[object Object]